A | |||||
---|---|---|---|---|---|
DBA/2 (H-2d) | Culture conditions | Antigenic stimulation (SI) 3Do-54.8 | Background (CPM) | ||
4 week old | BMMC, GM-CSF primed | OVA | OVAp | IgE-TNP-OVA | None |
WEHI-3 | 0.74 | 1.1 | .95 | 1,504 | |
D11 sup | .86 | .76 | .58 | 2,045 | |
Rec IL-3 | .75 | .80 | .63 | 1,786 | |
SCF | 1.3 | .67 | .75 | 1,745 | |
WEHI-3+SCF | .95 | .87 | 1.0 | 3,164 | |
WEHI-3+IL-4 | .79 | .83 | .87 | 2,568 | |
3 week old | BMMC, GM-CSF primed | ||||
WEHI-3 | 7.8* | 8.5* | 14.4* | 2,359 | |
SCF | 10.5* | 9.6* | 15.2* | 2,790 | |
WEHI-3+IL-4 | 8.5* | 7.4* | 22.3* | 3,876 | |
B10.BR (H-2 k ) | Antigenic stimulation (SI) AD10 | None | |||
4 week old | BMMC GM-CSF primed | PCC | PCCP | IgE-TNP-PCC | |
WEHI-3 sup | 1.4 | 1.3 | 0.8 | 2,140 | |
+IL-4 | 1.2 | 1.3 | .9 | 1,398 | |
3 week old | BMMC, GM-CSF primed | ||||
WEHI-3 | 14.4* | 9.8* | 18.2* | 2,575 | |
+IL-4 | 15.2* | 12.1* | 17.4* | 2,132 | |
B | |||||
DBA/2 (H-2 d ) | Culture conditions | Antigenic stimulation (SI) 3Do-54.8 | Background (CPM) | ||
Days old of BMMC | GM-CSF primed, in WEHI-3 media | IgE-TNP-OVA | None | ||
Day 22 | ibid. | 10.8* | 1,799 | ||
Day 23 | ibid. | 12.1* | 1,325 | ||
Day 24 | ibid. | 14.5* | 2,569 | ||
Day 25 | ibid. | 12.6* | 1,634 | ||
Day 26 | ibid. | 3.3* | 2,788 | ||
Day 27 | ibid. | 0.86 | 2,961 |